Celia Suriu

Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study

Eli Muchtar, Moshe E. Gatt, Ory Rouvio et al. · British Journal of Haematology · 2015 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome

Ilana Levy, Avital Lavi, Eran Zimran et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 34 citations

Medicine, Hematology, Infectious Diseases +10

Physicians’ lack of knowledge - a possible reason for red blood cell transfusion overuse?

Roni Rahav Koren, Celia Suriu, Orly Yakir et al. · Israel Journal of Health Policy Research · 2017 · 19 citations · Full text

Medicine, Internal Medicine, Medical Education +15

Outcomes of light‐chain amyloidosis patients treated with first‐line bortezomib: a collaborative retrospective multicenter assessment

Moshe E. Gatt, Izhar Hardan, Evgeni Chubar et al. · European Journal Of Haematology · 2015 · 16 citations

Medicine, Hematology, Oncology +13

Treatment patterns and clinical outcomes in high‐risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi‐center retrospective study

Yaël C. Cohen, Avi Saranga, Moshe E. Gatt et al. · American Journal of Hematology · 2018 · 16 citations · Full text

Medicine, Hematology, Oncology +15